Multi-center, randomized, double-blinded assessment of Tecfidera® in extending the time to a first attack in radiologically isolated syndrome (RIS) (ARISE)

Authors
Category Primary study
JournalMultiple Sclerosis
Year 2015
This article has no abstract
Epistemonikos ID: ab0818a9ac2268ca6fbc73ffb6e9da4869da88fb
First added on: Nov 19, 2025